Haisco Pharmaceutical Hits Day High with 6.61% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced a notable surge today, with the stock rising by 6.61% and reaching an intraday high of CNY 47.84. This performance stands in contrast to the China Shanghai Composite, which has only increased by 0.38% on the same day. Over the past week, Haisco has shown a modest gain of 0.9%, while the broader market has declined by 0.93%. However, the stock's performance over the past month reflects a slight decrease of 0.34, contrasting with the Shanghai Composite's increase of 1.44%. In terms of longer-term performance, Haisco has delivered a robust annual return of 37.51% over the past year, significantly outpacing the Shanghai Composite's 21.98%. Despite a year-to-date decline of 8.28%, the stock has demonstrated impressive growth over three and five-year periods, with returns of 88.2% and 112.79%, respectively. With a market capitalization of CNY 25,698 million, Haisco operates within the Pharmaceuticals & Biotechnology sector, showcasing a high dividend yield of 0.59% and a P/E ratio of 141.00.